Amanote Research
Register
Sign In
Safety and Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma With Portal Vein
HPB
- United Kingdom
doi 10.1016/j.hpb.2018.06.2642
Full Text
Open PDF
Abstract
Available in
full text
Categories
Hepatology
Gastroenterology
Date
September 1, 2018
Authors
Y. Shui
W. Yu
Q. Hu
X. Bai
L. Shen
T. Ma
T. Liang
Q. Wei
Publisher
Elsevier BV
Related search
Multicenter Planning Comparison of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Tumor Thrombosis (KROG 16-17)
Journal of Liver Cancer
Optimal Stereotactic Body Radiotherapy Dosage for Hepatocellular Carcinoma
Current Status of Stereotactic Body Radiotherapy for the Treatment of Hepatocellular Carcinoma
Yeungnam University Journal of Medicine
Management of Hepatocellular Carcinoma Patients With Portal Vein Thrombosis Using Three-Dimensional Conformal Radiotherapy
Journal of Cancer Therapy
Hepatocellular Carcinoma and Strongyloides Infection With Portal Vein Thrombosis
Journal of Liver Research, Disorders & Therapy
Pre-Operative Portal Vein Embolization for Hepatocellular Carcinoma.
Japanese Journal of Gastroenterological Surgery
Surgery
Gastroenterology
Factors Associated With Radiographic Response and Overall Survival After Stereotactic Ablative Radiation Therapy for Hepatocellular Carcinoma With Portal Vein Thrombosis
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Locoregenional Therapy for Hepatocellular Carcinoma: Transarterial Chemoembolization Versus Transarterial Radioembolization Versus Stereotactic Body Radiotherapy
Clinical Liver Disease
Hepatology
Efficacy of Proton Beam Therapy for Hepatocellular Carcinoma With Portal Vein or Inferior Vena Cava Tumor Thrombosis
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging